What is KAPA's current stock price?

KAPA (Kairos Pharma, Ltd.) is currently trading at $0.23 with a market cap of $5.0M.

What sector is Kairos Pharma, Ltd. in?

Kairos Pharma, Ltd. (KAPA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

KAPA Kairos Pharma, Ltd.

AMEXHealthcare

$0.2320-20.00%ClosedMarket Cap: $5.0M

As of 2026-08-24 16:00

Why KAPA matters now

Kairos Pharma, Ltd. (KAPA) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.23 with -20.00% on the session and $5.0M in market capitalization.

The latest indexable market news headline is "Kairos Pharma Announces 1-for-7 Reverse Stock Split" from Business Wire.

Latest News

Kairos Pharma Announces 1-for-7 Reverse Stock SplitBusiness Wire · 2026-08-21

Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate CancerBusiness Wire · 2026-07-22

CEO.CA's Inside the Boardroom: Kairos Pharma Might Change Cancer Treatment ForeverNewsfile Corp · 2026-07-15

Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance MarketBusiness Wire · 2026-07-15

All You Need to Know About Kairos Pharma, Ltd. (KAPA) Rating Upgrade to BuyZacks Investment Research · 2026-07-02

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

AMEX

Beta

1.56

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los Angeles, California.